Offerings - Spark Newswire

2 minute read

Natera Launches Proposed Follow-On Offering Of $350M Shares Of Common Stock

Today, 2:13 PM

Natera, Inc. (Nasdaq: NTRA) ("Natera"), a pioneer and global leader in cell-free DNA testing, today announced the launch of a proposed follow-on public offering of $350,000,000 of shares of its

NTRA

1 minute read

Natera Files For Stock Shelf Of Up To $350M

By Benzinga Newsdesk

Today, 2:13 PM

-SEC Filing

NTRA

1 minute read

Why Brickell Biotech Shares Are Trading Lower Today

By Bill Haddad

Today, 2:13 PM

Brickell Biotech (NASDAQ: BBI) shares are trading lower after the company announced a bought deal offering of common stock of $5 million, which was later increased to $7 million.

BBI

1 minute read

Why Cytokinetics (CYTK) Shares Are Trading Higher Today?

By Vandana Singh

Today, 2:13 PM

Cytokinetics Incorporated (NASDAQ: CYTK) shares continue to move forward after it announced positive REDWOOD-HCM Phase 2 data for CK-274 and garnered

CYTK

1 minute read

Datasea Raised $8.5M Via Secondary Institutional Equity Offering

By Anusuya Lahiri

Today, 2:13 PM

China’s intelligent security solutions provider Datasea Inc (NASDAQ:DTSS) has priced 2.4 million shares at $3.48 per share to raise $8.48 million in…

DTSS

1 minute read

Pacific Biosciences To Buy DNA Sequencing Firm For Up To $800M, Announces $300M Capital Raise For Deal Funding

By Vandana Singh

Today, 2:13 PM

Pacific Biosciences of California Inc (NASDAQ:PACB) has agreed to acquire Omniome, a San Diego-based company developing a short-read sequencing platform. …

NVTA

7 minute read

The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street

By Shanthi Rexaline

Today, 2:13 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19)

ABIO

1 minute read

Cytokinetics Announces Proposed $200M Public Offering of Common Stock

By Bill Haddad

Today, 2:13 PM

Cytokinetics, Incorporated (NASDAQ:CYTK) today announced plans to offer, subject to market and other conditions, $200,000,000 of shares of its common stock in an underwritten public offering. There can be no assurance as

CYTK

1 minute read

Cavitation Technologies Raises $1.5M In Equity Financing

By Akanksha

Today, 2:13 PM

Cavitation Technologies, Inc. (OTC: CVAT) has completed a financing of $1.50 million through the sale of ~23 million units.

CVAT

1 minute read

Skin-Disease Focused Biotech Castle Creek Files $100M IPO

By Vandana Singh

Today, 2:13 PM

Ahead of Phase 3 data readout in the second half of next year, Castle Creek Biosciences Inc (NASDAQ: CCBS) seeks to make NASDAQ debut under the symbol CCBS.

CCBS